Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 968, pseudogene (RNU6-968P) is classified as a pseudogene, specifically related to the U6 family of small nuclear RNAs (snRNAs). U6 snRNA is a highly conserved non-coding RNA that forms part of the spliceosome, where it plays a key role in RNA splicing, but RNU6-968P is neither a functional snRNA nor produces protein; instead, it is a non-functional genomic remnant resembling U6 RNA genes[3]. Pseudogenes like RNU6-968P are numerous in vertebrate genomes and are generally considered transcriptionally inactive and non-functional, though some pseudogenes can possess regulatory roles[2]. There is no evidence this pseudogene is a direct therapeutic target, nor associated disease, nor known drugs or biomarkers. Its functional parent, U6 snRNA, is essential to pre-mRNA splicing; however, pseudogenes including RNU6-968P do not contribute to these functions. Notes: - This is not a therapeutic target, enzyme, receptor, transporter, or commonly druggable biomolecule. - The query appears correct in terms of naming, but the target is a pseudogene—by most biomedical standards, this is not a "target" in the therapeutic sense and has no drug interactions or associated disease roles[3][2]. - No evidence could be found for biological function, disease association, biomarker status, or safety concerns. If you require information for a functional target related to the U6 family, the appropriate target would be U6 small nuclear RNA (snRNA), not its pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 968, pseudogene (RNU6-968P).